Lung Cancer Considered

Lung Cancer Considered

Por: IASLC
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by Current sponsors:
• AbbVie
• AstraZeneca
• Gilead
• J&J
• Summit
366 episodios disponibles

Latest episodes of the podcast Lung Cancer Considered

Mostrando página 9 de 19

Lung Cancer in MENA: Clinical and Research Initiatives 26/01/2024
IASLC - Oligometastatic Lung Cancer Part 2 23/01/2024
Lung Cancer Considered: A Three-Year Review 19/01/2024
IASLC Oligometastatic NSCLC 16/01/2024
Maximizing Supportive Care in Lung Cancer 26/12/2023
Lung Cancer in MENA: Clinical and Research Initiatives 22/12/2023
IASLC Chronic Toxicity From Targeted Therapy 19/12/2023
LCC in Korean: Managing EGFR+ NSCLC 15/12/2023
New Options for Initial Treatment of EGFR Mutant NSCLC 12/12/2023
Research from NACLC: Nutrition as Medicine and Lung Cancer Screening 08/12/2023
FDA Approval: Repotrectinib, a ROS1 and NTRK inhibitor 30/11/2023
FDA Approval: Perioperative Pembrolizumab and KEYNOTE 671 28/11/2023
It's time to talk about sexual health and lung cancer! 28/11/2023
Virtual Tumor Board: Neoadjuvant for Stage III NSCLC 21/11/2023
LCC in Dutch: Lung Cancer Care in The Netherlands 17/11/2023
AEGEAN and Beyond: Perioperative Immunotherapy for NSCLC 14/11/2023
Updated IASLC - Hindi 10/11/2023
FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC 06/11/2023
ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma 01/11/2023
ESMO 2023 Highlights: Metastatic NSCLC 30/10/2023
« Primera ‹ Anterior 1 ... 7 8 9 10 11 ... 19 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA